Dopamine transporter binding in Gilles de la Tourette syndrome

Journal of Neurology

Volumn 247, Issue 7, 2000, Pages 514-520

  Müller Vahl, Kirsten R ^a   Berding, Georg ^a   Brücke, Thomas ^b   Kolbe, Hans ^a   Meyer, Geerd J ^a   Hundeshagen, Heinz ^a   Dengler, Reinhard ^a   Knapp, Wolfram H ^a   Emrich, Hinderk M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b University Clinic of Neurology   (Austria)

Author keywords

2 carbomethoxy 3 (4 iodophenyl)tropane single photon; Dopamine transporter; Emission computed tomography; Gilles de la Tourette syndrome; Tics

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; DOPAMINE TRANSPORTER; IODINE 123;

ADULT; ARTICLE; AUTOMUTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; GILLES DE LA TOURETTE SYNDROME; HUMAN; ISOTOPE LABELING; MALE; OCCIPITAL CORTEX; PRIORITY JOURNAL; PROTEIN BINDING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0033908028     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007806     Document Type: Article

References (30)

1. 1. Boja JW, Patel A, Carroll FI, Rahman MA, Philip A, Lewin AH, Kopajtic TA, Kuhar MJ (1991) [125I]RTI-55: a potent ligand for dopamine transporters. Eur J Pharmacol 194:133-134
2. 2. Brücke T, Kornhuber J, Angelberger P, Asenbaum S, Frassine H, Podreka I (1993) SPECT imaging of dopamine and serotonin transporters with [123I]ß-CIT. Binding kinetics in the human brain. J Neural Transm 94:137-146
3. 3. Butler IJ, Koslow SH, Seifert WE, Caprioli RM, Singer HS (1979) Biogenic amine metabolism in Tourette syndrome. Ann Neurol 6:37-39
4. 4. Carroll FI, Gao YG, Rahman MA, Abraham P, Parham K, Lewin AH, Boja JW, Kuhar MJ (1991) Synthesis, ligand binding, QSAR and CoMFA study of 3b-(p-substituted phenyl)tropane-2ß-carboxylic acid methyl esters. J Med Chem 34:2719-2725
5. 5. Chang L (1978) A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci NS-25:638-643
6. 6. Cohen DJ, Shaywitz BA, Caparulo BK, Young JG, Bowers MB Jr (1978) Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration. Arch Gen Psychiatry 35:245-250
7. 7. Como PG (1995) Obsessive-compulsive disorder in Tourette's syndrome. Adv Neurol 65:281-291
8. 8. Dyck CH van, Seibyl JP, Malison RT, Laruelle M, Wallace E, Zoghbi SS, Zea-Ponce Y, Baldwin RM, Charney DS, Hoffer PB (1995) Age-related decline in striatal dopamine transporter binding with Iodine-123-ß-CIT SPECT. J Nucl Med 36:1175-1181
9. 9. George MS, Robertson MM, Costa DC, Ell PJ, Trimble MR, Pilowsky L, Verhoeff NP (1994) Dopamine receptor availability in Tourette's syndrome. Psychiatry Res 55:193-203
10. 10. Golden GS (1988) The relationship between stimulant medication and tics. Pediatr Ann 17:405-406:408
11. 11. Harcherik DF, Leckman JF, Detlor J, Cohen DJ (1984) A new instrument for clinical studies of Tourette's syndrome. J Am Acad Child Psychiatry 23:153-160
12. 12. Harrison AA, Everitt BJ, Robbins TW (1997) Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology (Berl) 133:329-342
13. 13. Heinz A, Knable MB, Wolf SS, Jones DW, Gorey JG, Hyde TM, Weinberger DR (1998) Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity. Neurology 51:1069-1074
14. 14. Innis RB, Seibyl JP, Scanley BE, Laruelle M, Abi-Dargham A, Wallace E, Baldwin RM, Zea-Ponce Y, Zoghbi S, Wang S, Gao Y, Neumeyer J, Charney D, Hoffer P, Marek K (1993) Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease. Proc Natl Acad Sci USA 90:11965-11969
15. 123I]ß-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse 13:295-309
16. 123I]ß-CIT SPECT imaging of striatal dopamine transporter binding in Tourette' disorder. Am J Psychiatry 152:1359-1361
17. 17. Müller-Vahl KR, Berding G, Kolbe H, Meyer GJ, Hundeshagen H, Dengler R, Knapp WH, Emrich HM (2000) Dopamine D2 receptor imaging in Gilles de la Tourette-Syndrome. Acta Neurol Scand 101:165-171
18. 18. Neumeyer JL, Wang SY, Milius RA, Baldwin RM, Zea-Ponce Y, Hoffer PB, Sybirska E, al-Tikriti M, Charney DS, Malison RT, Laruelle MA, Innis RB (1991) [123I]2ß-carboxymethoxy-3ß-(4-iodophenyl)-tropane (ß-CIT): high affinity SPECT radiotracer of monoamine re-uptake sites in brain. J Med Chem 34:3144-3146
19. 19. Robertson MM (1994) Annotation: Gilles de la Tourette Syndrome - An update. J Child Psychol Psychiatry 35:597-611
20. 123I]-ßCIT SPECT-study. Poster abstracts, 3rd International Scientific Symposium on Tourette Syndrome, June 4-6:1999, New York City (abstract)
21. 21. Seibyl JP, Wallace E, Smith EO, Stabin M, Baldwin RM, Zoghbi S, Zea-Ponce Y, Gao Y, Zhang WY, Neumeyer JL, Zabul G, Charney DS, Hoffer PB, Innis RB (1994) Whole-body biodistribution, radiation absorbed dose, and brain SPECT imaging with iodine-123-ß-CIT in healthy human subjects. J Nucl Med 35:764-770
22. 22. Seibyl JP, Marek KL, Quinlan D, Sheff K, Zoghbi S, Zea-Ponce Y, Baldwin RM, Fussell B, Smith EO, Charney DS, Hoffer PB, Innis RB (1995) Decreased Single-Photon Emission Computed Tomographic [123I] ß-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol 38:589-598
23. 23. Shapiro AK, Shapiro ES, Young JG, Feinberg TE (1988) Signs, symptoms, and clinical course. In: Shapiro AK, Shapiro ES, Young JG, Feinberg TE (eds) Gilles de la Tourette Syndrome, 2nd edn. Raven, New York, pp 127-193
24. 24. Shapiro E, Shapiro AK, Fulop G, Hubbard M, Mandeli J, Nordlie J, Phillips RA (1989) Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 46:722-730
25. 25. Singer HS, Hahn IH, Moran TH (1991) Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann Neurol 30:558-562
26. 26. Sivam SP (1995) GBR-12909-induced self-injurious behavior: role of dopamine. Brain Res 690:259-263
27. 27. Turjanski N, Sawle GV, Playford ED, Weeks R, Lammerstma AA, Lees AJ, Brooks DJ (1994) PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome. J Neurol Neurosurg Psychiatry 57:688-692
28. 28. Wolf SS, Jones DW, Knable MB, Gorey JG, Lee KS, Hyde TM, Coppola R, Weinberger DR (1996) Tourette Syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science 273:1225-1227
29. 29. Wong DF, Singer H, Marenco S, Brown J, Yung B, Yokoi F, Chan B, Mathews W, Musachio J, Dannals R (1994) Dopamine transporter reuptake sites measured by [C11]WIN 35:428 PET imaging are elevated in Tourette syndrome (abstract). J Nucl Med 35:130P
30. 30. Yokoyama C, Okamura H (1997) Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxy-dopamine-lesioned rat. I Dopaminergic neurons and receptors. J Pharmacol Exp Ther 280:1016-1030